Petros Pharmaceuticals, Inc. - Rentabilitas operasi PTPI

Logo perusahaan publik Petros Pharmaceuticals Inc (PTPI)

The adjusted operating margin demonstrates the efficiency of Petros Pharmaceuticals (PTPI), where 0.00 represents the latest level. Stability is ensured by the full localization of logistics within the US. Growth is based on the expansion of Stendra sales and the implementation of B2B digitalization. Diversification through telemedicine services and men's health products provides additional resilience, minimizing business risks.

Petros Pharmaceuticals Inc (PTPI): Rentabilitas kegiatan operasi saka 04.07.2022 nganti 28.06.2025

Petros Pharmaceuticals (PTPI) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:Petros Pharmaceuticals Inc, PTPI
Barang utama Petros Pharma

Operating margin measures the share of profit from core operations relative to total revenue, demonstrating cost management efficiency before taxes and interest. By analyzing the operating margin trend for Petros Pharmaceuticals (PTPI), an investor assesses the business's resilience to rising ingredient costs and regulatory risks, which helps determine the company's margin of safety when scaling its over-the-counter portfolio.

Pesaing utama

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|Margin dodolan operasi Tonix Pharmaceuticals Inc.|Rentabilitas operasi sxtchina.com|Margin dodolan operasi Eupraxia Pharmaceuticals (EPRX)|Margin operasi BHST|EXOZ - Rentabilitas dodolan operasi|Oramed - Margin dodolan operasi|Entera Bio Ltd. (ENTX) - Rentabilitas dodolan operasi|HYFT - Rentabilitas operasi|ABVC: Rentabilitas operasi|CPIX: Margin operasi|Quantum BioPharma Ltd. - Tingkat bathi operasi|FGEN (FibroGen Corp) - Margin operasi|Telomir Pharma (TELO) - Rentabilitas kegiatan operasi|Rentabilitas operasi Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Tingkat bathi operasi|Rentabilitas operasi Rallybio Corporation RLYB|LEXX: Rentabilitas dodolan miturut bathi operasi|PULM - Rentabilitas operasi|Tingkat bathi operasi PTHL (Pheton Holdings)|Aptorum (APM) - Rentabilitas operasi|LYRA (Lyra Therapeutics) - Rentabilitas operasi|Rentabilitas operasi Impact BioMedical Inc|TNF Pharmaceuticals - Margin bathi operasi|Margin operasi YCBD|Margin operasi PainReform Ltd. (PRFX)|Rentabilitas operasi Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Margin bathi operasi|OptiNose - Margin operasi|Margin bathi operasi PIRS|PROC: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.